InvestorsHub Logo
Followers 5
Posts 776
Boards Moderated 0
Alias Born 04/13/2012

Re: biotech_researcher post# 71514

Sunday, 02/21/2016 6:09:10 PM

Sunday, February 21, 2016 6:09:10 PM

Post# of 80490
"The FACT that Mr. Martin J. Duvall, Chief Commercial Officer and Exec. VP of Ariad earns $717,000 per year, and holds ONLY 79,000 shares after selling 14,000 in Q4 2015 speaks VOLUMES!. He KNOWS how Iclusig is selling now!"

The fact that he is the CCO, A.K.A VP of sales, and now only owns 79,000 shares after disposing of 14,000 shares in Q4 is very disturbing to me. My guess is $25-$35 million in Q4 sales"


this statement is a good point…but what is your point? you constantly bring forth negative speculation about ariad to this board. can you elaborate on why you constantly take a negative posture towards ariad pharmaceuticals? what is your agenda? thank you

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.